Example of Custom O2 focused on a security consultant’s need
In sequence to the Creating custom O2 Versions post, here is an example of a Custom O2 that is focused on a particular Security Consultant’s needs (in this case Matt Parsons which was doing some analysis using IBM’s AppScan Source Edition 7.x (previously known as Ounce 6.x))
Screenshots of Gui:
var title = "Matt Parsons"; var currentScript = PublicDI.CurrentScript; var ribbon = CustomO2.create(title, 1024,300); // stand alone version //var ribbon = CustomO2.create(panel.clear().add_Panel(),title); // use when inside 'Quick Development GUI' var appScanSource7Tab = ribbon.add_Tab("IBM AppScan Source 7.x"); var appScanSource6Tab = ribbon.add_Tab("IBM AppScan Source 6.x"); appScanSource7Tab.add_Group("Findings Viewer") .add_Script("7.x Findings Viewer", "Tool - Findings Viewer - IBM AppScan Source 7.0.h2"); appScanSource7Tab.add_Group("Support Files") .add_RibbonButton_ShowCodeFile("Schema File of *.ozasmt","xsd_Ozasmt_OunceV7_0.xsd".local()) .add_RibbonButton_ShowCodeFile("CSharp file of Schema File","xsd_Ozasmt_OunceV7_0.cs".local()); appScanSource6Tab.add_Group("Findings Viewer(s)") .add_Script("6.x Findings Viewer (with code viewer)", "Util - Simple Findings Viewer (with code viewer).h2") .add_Script("6.x Findings Viewer (just viewer/editor)", "Util - Simple Findings Viewer.h2") .add_Script("6.x Findings Viewer (indexed by Source-Code viewer)", "Util - Findings Viewer (filtered by SourceCode).h2") .add_Script("6.x and others Findings Viewer (separate GUI)", "Findings Viewer.h2"); var o2Scripting = ribbon.add_Tab("O2 Scripting"); o2Scripting.add_Group_developmentGuis(); ribbon.add_Tab_MiscTools(); o2Scripting.add_RibbonGroup("Custom O2") .add_RibbonButton("Edit this Custom O2 Script", () => O2Gui.open<Panel>("Custom O2",800,400) .add_SourceCodeEditor() .open(currentScript)); ribbon.add_Tab_BrowserAutomation(); return "done"; //O2File:WPF_Ribbon_ExtensionMethods.cs //O2File:CustomO2.cs //O2Ref:WindowsFormsIntegration.dll //O2Ref:RibbonControlsLibrary.dll
No comments yet.